Fraxiparine

Fraxiparine is a medication containing Nadroparin Calcium, used for anticoagulation. It is suitable for subcutaneous or intravenous administration, including during haemodialysis.

Fraxiparine is primarily used to prevent and treat blood clots. It is often administered to patients undergoing haemodialysis to maintain the patency of the dialysis circuit. This medication is also used for subcutaneous injection to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) in certain high-risk individuals. What is Fraxiparine used for? It is commonly prescribed for anticoagulation in various medical settings.

Common effects of Fraxiparine may include bruising, bleeding, and pain at the injection site. Some users might experience allergic reactions, though these are less frequent. It is important to monitor for signs of unusual bleeding, as this can indicate an adverse reaction to the medication.

Fraxiparine should be handled with care to avoid contamination. It is essential to follow the prescribed dosage and administration route, whether subcutaneous or intravenous. Patients should inform their healthcare provider about any history of bleeding disorders or allergies before starting this medication.

Fraxiparine may interact with other anticoagulants, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antibiotics. Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always consult a healthcare provider before combining Fraxiparine with other medications.